InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the full record of transactions filed by Patel Naimish. Director active across 1 company, notably CRISPR Therapeutics AG. In total, 2 filings have been recorded. Split: 0 buy · 1 sell. Total volume traded: €181k. History available since 29 May 2026. The latest transaction was filed on 29 May 2026 (Cession). Regulator: SEC (Form 4). All data is free.
2 of 2 declarations